Search Results
Aug 24, 2026, 08:00 ET LEQEMBI IQLIK®(lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease
https://www.nia.nih.gov/health/memory-loss-and-forgetfulness/what-mild-cognitive-impairment. Accessed July 22, 2026.Amin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021;12:3451.
More news about: Eisai Inc.
Aug 24, 2026, 06:30 ET XPENG Reports Second Quarter 2026 Unaudited Financial Results
2026.As of July 31, 2026, year-to-date total deliveries were 204,004 vehicles.Launch of MONA L03On July 16, 2026, XPENG held the global launch event of MONA L03, the Next-Gen AI SUV Coupe, in Munich, Germany.Entering into the Dogotix Share Purchase AgreementOn
More news about: XPeng Inc.
Aug 24, 2026, 01:03 ET Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
expertise, Roche is advancing a portfolio designed to meet the diverse needs of people living with obesity and related health conditions," said Boris L. Zaïtra, head of Roche Corporate Business Development. "By licensing this next-generation investigational therapy with first-in-class potential from Hanmi,
More news about: Hanmi Pharm. Co., Ltd.
Aug 24, 2026, 00:40 ET Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
expertise, Roche is advancing a portfolio designed to meet the diverse needs of people living with obesity and related health conditions," said Boris L. Zaïtra, head of Roche Corporate Business Development. "By licensing this next-generation investigational therapy with first-in-class potential from Hanmi,
More news about: Hanmi Pharm. Co., Ltd.
Aug 23, 2026, 22:30 ET Coway Raih Penghargaan IDEA Design Awards 2026, Lengkapi "Grand Slam" Desain Internasional
pembersihan dan perawatan menjadi semakin mudah.Inverter Dehumidifier 23L:Performa Lebih Cepat: Dengan kapasitas hingga 23 liter per hari, Inverter Dehumidifier 23L mampu mencapai tingkat kelembapan optimal dalam 30 menit, atau tiga kali lebih cepat dibandingkan
More news about: Coway Co., Ltd.
Aug 23, 2026, 21:00 ET Antengene Announces 2026 Interim Results: Achieves First‑Ever Profitability and Accelerates Value Creation Through Innovative R&D
Registration, 1L Leadership, and Broader Patient Reach: CLINCH-3 provides a near-term registration pathway for ATG-022 monotherapy at the optimized 1.8 mg/kg dose in 3L+ gastric/GEJ cancer with CLDN18.2 IHC 2+ ≥ 20%, establishing ATG-022 in gastric cancer. CLINCH-2 is evaluating ATG-022 in 1L in combination
More news about: Antengene Corporation Limited
Aug 22, 2026, 11:35 ET RayNeo erweitert sein AR-Sortiment für Endverbraucher: Vorstellung der RayNeo iO Smart-Brillen und der kinotauglichen RayNeo GT-Serie
Gehäuse leichten Tragekomfort. Die GT Max ist in drei Größen für den Pupillenabstand (IPD) erhältlich (Größe S: <64 mm | Größe M: 64–67 mm | Größe L: >67 mm), um bei allen Gesichtsformen optimale optische Klarheit zu gewährleisten.Modellvergleich
More news about: RayNeo
Aug 22, 2026, 11:32 ET RayNeo élargit sa gamme de produits de réalité augmentée grand public : présentation des lunettes connectées RayNeo iO et de la série RayNeo GT cinématographique
une grande légèreté. Le GT Max est disponible en 3 tailles en fonction de l'écart interpupillaire (Taille S : < 64 mm | Taille M : 64–67 mm | Taille L : > 67 mm) afin de garantir une clarté optique quelle que soit la forme du visage.Comparaison de modèles
More news about: RayNeo
Aug 21, 2026, 12:15 ET Greenberg Traurig Earns Top Recognitions in The Best Lawyers in America®, Best Lawyers: Ones to Watch® in America 2027 Editions
Kerri L. Barsh: Litigation – Land Use and Zoning,
More news about: Greenberg Traurig, LLP
Aug 21, 2026, 12:05 ET Indiana American Water and American Water Charitable Foundation Support Disaster Recovery Efforts Across Indiana
and wastewater services through the storms."When weather events impact Indiana communities, our employees don't hesitate to step up," said Barry L. Suits, President of Indiana American Water. "Whether they're helping maintain critical water and wastewater systems or supporting emergency response
More news about: American Water
Aug 21, 2026, 11:10 ET In HelloNation, Insurance Expert James L. Reagle Discusses How to Determine Homeowners Insurance Needs
an article featuring insights from Insurance Expert James L. Reagle of Reagle Insurance that provides the answer.The article explains that choosing homeowners insurance involves more than looking at a property's
More news about: HelloNation
Aug 21, 2026, 10:05 ET Summary Notice to Stockholders of Spartan Acquisition Corp. II as of July 6, 2021
a.m., before The Honorable Paul A. Fioravanti, Jr., Vice Chancellor, either in person at the Court of Chancery of the State of Delaware, Leonard L. Williams Justice Center, 500 North King Street, Wilmington, Delaware, 19801, or remotely by telephone or videoconference (in the discretion of the Court),
More news about: Levi & Korsinsky, LLP
Aug 21, 2026, 10:00 ET Greenberg Traurig's Brad Kaufman Named Finalist for American Lawyer Industry Awards Best Mentor
Tracy L. Gerber, a mentee who has risen to become managing shareholder of the firm's
More news about: Greenberg Traurig, LLP
Aug 21, 2026, 08:58 ET Henlius Reports 2026 Interim Results: Sustained Profitability Leap, Advancing Global Value Validation, and Accelerating Progress Towards C-MNC
high-potential innovative assets—including the PD-L1 ADC HLX43 and the novel epitope anti-HER2 mAb dulpatatug (HLX22) — are advancing through global pivotal clinical development. Supported by a biologics manufacturing network with a total capacity of 84,000L and GMP certifications from regulatory authorities
More news about: Henlius
Aug 21, 2026, 08:37 ET 復宏漢霖2026年中期業績：盈利能力持續躍升，進入全球價值兌現期
圍內推進臨床開發，業績期內研發投入達14.507億元，同比增長45.7%。公司差異化創新管線儲備持續擴容，已形成下一代IO、Hanjugator ADC、多特異性TCE及AI 等技術平台，儲備50餘個在研早期分子，覆蓋腫瘤、免疫炎症、神經和代謝等領域。核心資產HLX43作為潛在同類最優（BIC）的廣譜抗腫瘤PD-L1 ADC，在非小細胞肺癌（NSCLC）等多個實體瘤中已展現出「高效、低毒」的初步臨床療效，其在NSCLC領域的II期及II/III期國際多中心研究已於中國、歐洲、美國、日本及澳大利亞等國家和地區推進，其中晚期sqNSCLC II/III期研究已獲日本PMDA默示許可並
More news about: 復宏漢霖
Aug 21, 2026, 07:45 ET AbbVie to Present New Data at WCLC 2026 Showcasing Innovation Across Lung Cancer Pipeline
combination of Temab-A and a PD-1 inhibitor, as a potential first-line treatment for advanced non-squamous NSCLC. The study includes analyses of c-Met and PD-L1 expression to identify the patients most likely to benefit from treatment.3 Temab-A is also being studied in epidermal growth factor receptor
More news about: AbbVie
Aug 21, 2026, 07:09 ET Eightco Holdings (NASDAQ: ORBS) rende noto un portafoglio complessivo di circa 389 milioni di dollari, che comprende OpenAI, Beast Industries, oltre 16.000 ETH e quasi 302 milioni di token WLD
circa il doppio delle tipologie di attività.Identità digitale: token WLDEightco detiene quasi 302 milioni di WLD, pari a circa l'8,4% dell'offerta circolante, la più grande posizione istituzionale resa pubblica a livello globale e che costituisce circa il 29% degli asset di tesoreria
More news about: Eightco Holdings (NASDAQ: ORBS)
Aug 21, 2026, 05:20 ET Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) NDA Accepted by NMPA, Poised to Become World's First Approved 4-1BB-Targeting Therapy
(NDA) for Opamtistomig (LBL-024), the Company's proprietary PD-L1/4-1BB bispecific antibody, as a monotherapy for the treatment of previously treated advanced extrapulmonary neuroendocrine carcinoma (EP-NEC). Opamtistomig is the first PD-L1/4-1BB bispecific antibody globally to enter NDA review and
More news about: Nanjing Leads Biolabs Co., Ltd.
Aug 21, 2026, 05:13 ET Keymed Biosciences Announces 2026 H1 Results and Business Updates
(CD38 mAb) in second‑line RRMM was accepted.Keymed operates 6 integrated platforms, with Chengdu production capacity of 21,800L (plus 24,000L stainless steel lines soon operational). As of June 30, 1,768 full‑time employees, including 500 in commercial and 420 in R&D/clinical.
More news about: Keymed Biosciences
Aug 21, 2026, 03:24 ET 3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth
tumors, standing as the only drug with this target actively advancing in clinical stages in China, demonstrating significant differentiation. 706 (anti-PD-1/PD-L1 bispecific antibody) has entered Phase II trials for advanced non-small cell lung cancer and advanced gastrointestinal tumors. 708 (anti-PD-1/TGFβ
More news about: 3SBio Inc.
Aug 21, 2026, 03:00 ET Coway bei den IDEA Design Awards 2026 ausgezeichnet - „Grand Slam" im internationalen Design perfekt gemacht
Der Inverter Dehumidifier 23L (Inverter-Luftentfeuchter) besticht durch ein elegantes, zweifarbiges Design, das sich nahtlos in jede Inneneinrichtung einfügt und die Gesamtästhetik eines Raums mühelos aufwertet.Flexible Mobilität: Der Inverter Dehumidifier 23L (Inverter-Luftentfeuchter)
More news about: Coway Co., Ltd.
Aug 21, 2026, 03:00 ET Coway récompensé aux IDEA Design Awards 2026, réalise le « grand chelem » international du design
d'une sortie d'air supérieure antistatique entièrement amovible et lavable, pour un entretien sans effort.L' Inverter Dehumidifier 23L :Performance puissante : grâce à sa capacité journalière généreuse de 23 litres, l'Inverter Dehumidifier
More news about: Coway Co., Ltd.
Aug 21, 2026, 03:00 ET RayNeo Expands Consumer AR Lineup: Unveiling RayNeo iO Smart Glasses and Cinematic RayNeo GT Series
streamlined chassis offers lightweight comfort. The GT Max comes in 3 physical Interpupillary Distance (IPD) sizes (Size S: <64mm | Size M: 64–67mm | Size L: >67mm) to guarantee optical clarity across face shapes.Model Comparison
More news about: RayNeo
Aug 21, 2026, 03:00 ET RayNeo Expands Consumer AR Lineup: Unveiling RayNeo iO Smart Glasses and Cinematic RayNeo GT Series
streamlined chassis offers lightweight comfort. The GT Max comes in 3 physical Interpupillary Distance (IPD) sizes (Size S: <64mm | Size M: 64–67mm | Size L: >67mm) to guarantee optical clarity across face shapes.Model Comparison
More news about: RayNeo
Aug 21, 2026, 03:00 ET RayNeo amplía su gama de realidad aumentada para el consumidor
una comodidad excepcional. Las GT Max están disponibles en 3 tamaños de distancia interpupilar (IPD) (Talla S: <64 mm | Talla M: 64–67 mm | Talla L: >67 mm) para garantizar una claridad óptica óptima en diferentes formas de rostro.Comparación de modelos
More news about: RayNeo